Why Investors Need to Take Advantage of These 2 Construction Stocks Now
https://www.zacks.com/stock/news/2196055/why-investors-need-to-take-advantage-of-these-2-construction-stocks-now?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_earnings_esp-2196055
Dec 11, 2023 - Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
0
If You Invested $1000 in Insulet a Decade Ago, This is How Much It'd Be Worth Now
https://www.zacks.com/stock/news/2196021/if-you-invested-1000-in-insulet-a-decade-ago-this-is-how-much-it-d-be-worth-now?cid=CS-ZC-FT-tale_of_the_tape|investing_$1000-2196021
Dec 11, 2023 - Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
0
If You Invested $1000 in Fiserv a Decade Ago, This is How Much It'd Be Worth Now
https://www.zacks.com/stock/news/2196020/if-you-invested-1000-in-fiserv-a-decade-ago-this-is-how-much-it-d-be-worth-now?cid=CS-ZC-FT-tale_of_the_tape|investing_$1000-2196020
Dec 11, 2023 - Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
0
Walgreens' (WBA) AllianceRx Pharmacy Will Now Distribute XDEMVY
https://www.zacks.com/stock/news/2196004/walgreens-wba-alliancerx-pharmacy-will-now-distribute-xdemvy?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2196004
Dec 11, 2023 - Walgreens' (WBA) subsidiary, AllianceRx Walgreens Pharmacy, is one of the four specialty pharmacies selected to distribute XDEMVY.
0
Why Arch Capital (ACGL) Shares Are Attracting Investors Now
https://www.zacks.com/stock/news/2195998/why-arch-capital-acgl-shares-are-attracting-investors-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2195998
Dec 11, 2023 - Arch Capital (ACGL) stands to gain from new business opportunities, rate increases, strategic acquisitions and a solid capital position.
0
Reasons to Add OGE Energy (OGE) to Your Portfolio Right Now
https://www.zacks.com/stock/news/2195977/reasons-to-add-oge-energy-oge-to-your-portfolio-right-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2195977
Dec 11, 2023 - OGE Energy (OGE) makes a strong case for investment, given its positive growth estimates, strong financial position and systematic investments.
0
Is AHITX a Strong Bond Fund Right Now?
https://www.zacks.com/stock/news/2195968/is-ahitx-a-strong-bond-fund-right-now?cid=CS-ZC-FT-mutual_fund_bond-2195968
Dec 11, 2023 - MF Bond Report for AHITX
0
Is VAIPX a Strong Bond Fund Right Now?
https://www.zacks.com/stock/news/2195969/is-vaipx-a-strong-bond-fund-right-now?cid=CS-ZC-FT-mutual_fund_bond-2195969
Dec 11, 2023 - MF Bond Report for VAIPX
0
Is VWITX a Strong Bond Fund Right Now?
https://www.zacks.com/stock/news/2195967/is-vwitx-a-strong-bond-fund-right-now?cid=CS-ZC-FT-mutual_fund_bond-2195967
Dec 11, 2023 - MF Bond Report for VWITX
0
Is Fidelity Select Portfolio Medical Technology and Devices (FSMEX) a Strong Mutual Fund Pick Right Now?
https://www.zacks.com/stock/news/2195971/is-fidelity-select-portfolio-medical-technology-and-devices-fsmex-a-strong-mutual-fund-pick-right-now?cid=CS-ZC-FT-mutual_fund_equity_report-2195971
Dec 11, 2023 - Mutual Fund Report for FSMEX
0